mAbxience and Sandoz have formed a collaboration to develop, manufacture, and commercialize a biosimilar candidate for emicizumab, a treatment for hemophilia A. mAbxience will handle development and manufacturing in Spain and Argentina, while Sandoz will manage global commercialization except in Argentina, Uruguay, and Paraguay. This partnership aims to expand patient access to affordable biologic medicines for hemophilia A, a rare genetic disorder with a significant unmet medical need. The deal strengthens mAbxience's presence in rare diseases and complements its growing biosimilar pipeline across multiple therapeutic areas.
The collaboration between mAbxience and Sandoz to advance biosimilar access worldwide is presented here with Pluang's Health-sector market data as of Sep 18, 2026 15:41 WIB. Among 91 priced US Health-sector stocks on Pluang, 40 rose and 41 fell. Notable movers include GSK at USD 50.25 with a 1-day change of -1.59% and 100% sell order activity, Koninklijke Philips NV at USD 24.33 with a -1.42% change and 100% buy order activity, and Ginkgo Bioworks Holdings Inc at USD 7.95 with a +1.40% change and 100% buy order activity.
Meta's stock has rebounded nearly 20% recently, driven by optimism around its upcoming AI launch and strong ad revenue growth. Despite a sharp drop in free cash flow due to heavy capital expenditures, Meta's ad business continues to expand, with a 27...
The recently launched ACBE ETF uses autocallable structured notes to generate income, offering a different risk-return profile compared to traditional covered-call ETFs like JEPI. It aims to deliver bond-like income through equity-linked contracts bu...
Chanson International Holding reported a net income of $0.8 million for the first half of fiscal 2026, recovering from a $1.0 million loss in the same period last year. Total revenue slightly declined by 4.5% to $8.3 million, mainly due to decreased ...
Micron Technology is set to release its fiscal Q4 2026 earnings report, expected to show a record net margin of 70.7%, driven by strong demand from AI applications. While near-term optimism is high due to margin expansion, there is skepticism about t...
AGNC Investment Corp., a Mortgage REIT, offers various preferred stocks with different risk and yield profiles for income investors. While dividend coverage remains strong at nearly 13 times, par value coverage has dropped to 5.4 times due to a signi...
